KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Deferred Tax Assets (2016 - 2017)

Teva Pharmaceutical Industries filings provide 9 years of Current Deferred Tax Assets readings, the most recent being $28.7 billion for Q3 2017.

  • On a quarterly basis, Current Deferred Tax Assets rose 2646.26% to $28.7 billion in Q3 2017 year-over-year; TTM through Sep 2017 was $28.7 billion, a 2646.26% increase, with the full-year FY2016 number at $1.1 billion, up 46.39% from a year prior.
  • Current Deferred Tax Assets hit $28.7 billion in Q3 2017 for Teva Pharmaceutical Industries, up from $28.0 billion in the prior quarter.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $33.3 billion in Q4 2016 to a low of $23.3 million in Q4 2014.
  • Median Current Deferred Tax Assets over the past 5 years was $1.1 billion (2014), compared with a mean of $9.9 billion.
  • The widest YoY moves for Current Deferred Tax Assets: up 4435.65% in 2016, down 96.44% in 2016.
  • Teva Pharmaceutical Industries' Current Deferred Tax Assets stood at $47.4 million in 2013, then tumbled by 50.84% to $23.3 million in 2014, then soared by 3054.51% to $735.0 million in 2015, then skyrocketed by 4435.65% to $33.3 billion in 2016, then dropped by 14.0% to $28.7 billion in 2017.
  • The last three reported values for Current Deferred Tax Assets were $28.7 billion (Q3 2017), $28.0 billion (Q2 2017), and $1.0 billion (Q1 2017) per Business Quant data.